Israel Englander Nuvectis Pharma, Inc. Call Options Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCT
# of Institutions
41Shares Held
1.84MCall Options Held
0Put Options Held
0-
Ronit Capital LLP563KShares$4.81 Million5.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA251KShares$2.15 Million0.0% of portfolio
-
Baldwin Brothers LLC174KShares$1.49 Million0.08% of portfolio
-
Black Rock Inc. New York, NY83.4KShares$713,1720.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny74.5KShares$636,9750.0% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $125M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...